GALECTIN THERAPEUTICS INC — Director's Dealing 2015

Jul 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2015-03-12

Reporting Person: Prelack Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-12	Common Stock	A	11112	—	Acquired	14048	Direct
2015-04-08	Common Stock	A	2259	—	Acquired	16307	Direct
2015-04-08	Common Stock	A	90882	—	Acquired	107189	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-08	Stock Option (right to buy)	$7.08	D	6168	Disposed	2021-06-28	Common Stock (6168)	Direct
2015-04-08	Stock Option (right to buy)	$3.59	D	16714	Disposed	2023-03-28	Common Stock (16714)	Direct

Footnotes

F1: The option vested as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011.

F2: The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 19,504 shares of restricted common stock, reported in Table 1 of this Form 4 as a part of the April 8, 2015 grant of 90,882 shares, as consideration for the cancellation of options granted on June 28, 2011 and March 28, 2013.

F3: The option vested quarterly in eight equal installments beginning on May 12, 2013.